Your browser doesn't support javascript.
loading
Intrinsic coagulant potential modulates anticoagulant efficacy of rivaroxaban.
Pereira Portela, Cindy; Stirnimann, Guido; Kröll, Dino; Aliotta, Alessandro; Veuthey, Lucas; Zermatten, Maxime G; Alberio, Lorenzo; Bertaggia Calderara, Debora.
Afiliación
  • Pereira Portela C; Division of Hematology and Central Hematology Laboratory, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland.
  • Stirnimann G; Department of Visceral Surgery and Medicine, Inselspital, University Hospital and University of Bern, Bern, Switzerland.
  • Kröll D; Department of Visceral Surgery and Medicine, Inselspital, University Hospital and University of Bern, Bern, Switzerland.
  • Aliotta A; Division of Hematology and Central Hematology Laboratory, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland.
  • Veuthey L; Division of Hematology and Central Hematology Laboratory, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland.
  • Zermatten MG; Division of Hematology and Central Hematology Laboratory, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland.
  • Alberio L; Division of Hematology and Central Hematology Laboratory, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland. Electronic address: lorenzo.alberio@chuv.ch.
  • Bertaggia Calderara D; Division of Hematology and Central Hematology Laboratory, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland.
Thromb Res ; 237: 34-36, 2024 May.
Article en En | MEDLINE | ID: mdl-38547692

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Rivaroxabán / Anticoagulantes Límite: Humans / Male Idioma: En Revista: Thromb Res Año: 2024 Tipo del documento: Article País de afiliación: Suiza Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Rivaroxabán / Anticoagulantes Límite: Humans / Male Idioma: En Revista: Thromb Res Año: 2024 Tipo del documento: Article País de afiliación: Suiza Pais de publicación: Estados Unidos